← 返回

评估不同无血清培养条件对 NK 细胞来源细胞外囊泡产量与功能的影响

英文原题:Evaluating the Influence of Different Serum-Free Culture Conditions on the Production and Function of Natural Killer Cell-Derived Extracellular Vesicles.

查看英文原题

Evaluating the Influence of Different Serum-Free Culture Conditions on the Production and Function of Natural Killer Cell-Derived Extracellular Vesicles.

PubMed 2025/04/25(内容时间) J Extracell Biol Q2 · IF 4.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

自然杀伤(NK)细胞被用于癌症细胞疗法。虽然NK细胞疗法对血液系统恶性肿瘤有效,但因肿瘤浸润不足及肿瘤微环境恶劣,靶向实体瘤较困难。NK细胞来源细胞外囊泡(NK-EV)可在体外靶向并杀伤癌细胞,是实体瘤的替代治疗策略。为发挥其潜力,有必要标准化NK-EV生产方案。本研究比较了人NK-92细胞系在5种针对NK细胞生长优化的无血清商业培养基及1种淋巴细胞无血清培养基中培养所产生的EV,并比较静态培养与摇瓶培养的影响。采用超速离心后接尺寸排阻色谱纯化EV。静态或动态培养的NK-92细胞EV产量无显著差异。但不同培养基之间EV纯度存在明显差异,表现为分离物中CD63和CD81标志物富集程度不同,并进一步影响其诱导结肠癌HCT 116细胞凋亡的能力。这些发现有助于设计未来治疗性NK细胞来源EV的生产方案。

展开英文摘要原文

Natural killer (NK) cells are exploited in cellular therapies for cancer. While NK cell therapies are efficient against haematological cancers, it has been difficult to target solid tumours due to low tumour infiltration and a hostile tumour microenvironment. NK-cell derived extracellular vesicles (NK-EVs) target and kill cancer cells in vitro and represent an alternative treatment strategy for solid tumours. To exploit their potential, it is necessary to standardize NK-EV production protocols.

Here, we have performed a comparative analysis of EVs from the human NK-92 cell line cultured in five serum-free commercial media optimized for growth of human NK cells and one serum-free medium for growth of lymphocytes. The effect of growing the NK-92 cells in static cell cultures versus shaking flasks was compared. EVs were purified via ultracentrifugation followed by size-exclusion chromatography.

We found that there were no significant differences in EV yield from NK-92 cells grown under static or dynamic conditions.

However, we found clear differences between the different culture media in terms of EV purity as assessed by the enrichment of the CD63 and CD81 markers in the isolates that translated into their capacity to induce apoptosis of the colon cancer cell line HCT 116.

These findings will be instructive for the design of future production protocols for therapeutic NK-cell derived EVs.

论文信息

作者
Wu Y、Chollet H、Sudworth A、Inngjerdingen M
单位
Department of Pharmacology Institute of Clinical Medicine University of Oslo Oslo Norway.Norway
期刊
Journal of extracellular biology2025 Apr
原文标识
PubMed 40292387 · DOI 10.1002/jex2.70049